Stock listing
A40DQD Stock Price, News, Filings & Events — Xtalpi Holdings Limited
Selected listing: A40DQD · LS · EUR · DE
This page tracks Xtalpi Holdings Limited's A40DQD:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A40DQD:LS. A40DQD:LS is the stock-level entry point for investors researching Xtalpi Holdings Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A40DQD:LS
- Asset type
- Stock
- Market cap
- $3.78B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LS
- Currency
- EUR
Xtalpi Holdings Limited A40DQD:LS stock context
This page tracks Xtalpi Holdings Limited's A40DQD:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A40DQD:LS. A40DQD:LS is the stock-level entry point for investors researching Xtalpi Holdings Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Xtalpi Holdings Limited
XtalPi AI Enables Seven-Month PCC Nomination for Viva-Thera's MPER-Targeting HIV-1 Program
September 22, 2026
XtalPi Holdings Limited to Announce 2026 Interim Results on August 19, 2026
August 11, 2026
XtalPi Announces Strategic Partnership with a Leading Biopharma to Develop Oral Small Molecule Therapeutics for a GPCR Target
June 10, 2026
XtalPi Receives Second Payment from DoveTree; First Oncology Asset Advances into IND-Enabling Studies
May 29, 2026
XtalPi -Enabled PharmaEngine PEP08 Achieves Enrollment Milestone, with Second Synthetic Lethality Program Underway
May 3, 2026
Research Xtalpi Holdings Limited
Xtalpi Holdings Limited investor report
Review AI stock analysis and investor report context for A40DQD:LS.
Xtalpi Holdings Limited company profile
View the public company page for Xtalpi Holdings Limited on 6ix.
Xtalpi Holdings Limited news
Read company news and market updates connected to Xtalpi Holdings Limited.
Xtalpi Holdings Limited investor events
Find investor webinars, events, and replay context for Xtalpi Holdings Limited.
Alternate listings
2228:HKEX
HK · HKD
Alternate listing for Xtalpi Holdings Limited; the primary context on this page is A40DQD:LS.
QNTPF:OTC
US · USD
Alternate listing for Xtalpi Holdings Limited; the primary context on this page is A40DQD:LS.
A40DQD:LSX
DE · EUR
Alternate listing for Xtalpi Holdings Limited; the primary context on this page is A40DQD:LS.
V0I:TRADEGATE
DE · EUR
Alternate listing for Xtalpi Holdings Limited; the primary context on this page is A40DQD:LS.
V0I:FWB
DE · EUR
Alternate listing for Xtalpi Holdings Limited; the primary context on this page is A40DQD:LS.